IgG Fab Glycans Hinder FcRn-Mediated Placental Transport
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200438 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Mikhail Volkov und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Autoimmune Diseases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: ReumaNederland, IMI.
Abstract (Originalsprache)
Abs can be glycosylated in both their Fc and Fab regions with marked effects on Ab function and binding. High levels of IgG Fab glycosylation are associated with malignant and autoimmune conditions, exemplified by rheumatoid arthritis and highly Fab-glycosylated (∼90%) anti-citrullinated protein Abs (ACPAs). Important properties of IgG, such as long half-life and placental transport, are facilitated by the human neonatal Fc receptor (hFcRn). Although it is known that glycosylation of Abs can affect binding to Fc receptors, little is known on the impact of IgG Fab glycosylation on hFcRn binding and transplacental transport. Therefore, we analyzed the interaction between hFcRn and IgG with and without Fab glycans in vitro with various methods as well as in vivo by studying placental transfer of Fab-glycosylated Abs from mothers to newborns. No effect of Fab glycosylation on IgG binding to hFcRn was found by surface plasmon resonance and hFcRn affinity chromatography. In contrast, studies in a cell membrane context revealed that Fab glycans negatively impacted IgG–hFcRn interaction. In line with this, we found that Fab-glycosylated IgGs were transported ∼20% less efficiently across the placenta. This appeared to be a general phenomenon, observed for ACPAs, non-ACPAs, as well as total IgG in rheumatoid arthritis patients and healthy controls. Our results suggest that, in a cellular context, Fab glycans inhibit IgG–hFcRn interaction and thus negatively affect the transplacental transfer of IgG. As Fab-glycosylated Abs are frequently associated with autoimmune and malignant disorders and may be potentially harmful, this might encompass a regulatory mechanism, limiting the half-life and transport of such Abs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Department of Rheumatology, Erasmus University Medical Center, Rotterdam, the Netherlands; and.
- International Health Centre-Polikliniek Prins Willem, The Hague, the Netherlands.
ORCID-Profile: Mikhail Volkov, Maximilian Brinkhaus, Karin A van Schie, Albert Bondt, Theresa Kissel, Arthur E H Bentlage, Carolien A M Koeleman, Steven W de Taeye, Ninotska I Derksen, Manfred Wuhrer, René E M Toes, Gestur Vidarsson
Förderung
- ReumaNederland
- IMI
Zitieren
APA
Volkov, M., Brinkhaus, M., van Schie, K. A., Bondt, A., Kissel, T., van der Kooi, E. J., Bentlage, A. E. H., Koeleman, C. A. M., de Taeye, S. W., Derksen, N. I., Dolhain, R. J. E. M., Braig-Scherer, U., Huizinga, T. W. J., Wuhrer, M., Toes, R. E. M., Vidarsson, G., & van der Woude, D. (2023). IgG Fab Glycans Hinder FcRn-Mediated Placental Transport. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200438
Vancouver
Volkov M, Brinkhaus M, van Schie KA, Bondt A, Kissel T, van der Kooi EJ, et al. IgG Fab Glycans Hinder FcRn-Mediated Placental Transport. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200438
BibTeX
@article{Volkov2023,
author = {Volkov, Mikhail and Brinkhaus, Maximilian and van Schie, Karin A and Bondt, Albert and Kissel, Theresa and van der Kooi, Elvera J and Bentlage, Arthur E H and Koeleman, Carolien A M and de Taeye, Steven W and Derksen, Ninotska I and Dolhain, Radboud J E M and Braig-Scherer, Ute and Huizinga, Tom W J and Wuhrer, Manfred and Toes, René E M and Vidarsson, Gestur and van der Woude, Diane},
title = {IgG Fab Glycans Hinder FcRn-Mediated Placental Transport},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200438}
}
EUVIMED